ASND

Ascendis A/SF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

ASND vs peer average

15/100

ASND vs. peer average (F vs. C)

Grade spread

B 3 · C 7 · D 1

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

LLY is the first available peer comparator.

Large endocrinology/diabetes-focused pharma with strong commercialization capability — useful comparator for market access dynamics.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerLLYEli Lilly and

ASND

Ascendis A/S

LLY

Eli Lilly and

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Defensive

Constructive

Open Side-by-Side Comparison Compare all

Grade position vs LLY

ASND / LLY

Grade Position

Below peers

ASND vs. peer average (F vs. C)

15/100

Momentum

ASND

Value

LLY

Sentiment

LLY

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs ASND

LLY

80/100

-3

NVO

60/100

-2

AMGN

40/100

-1

BBIO

BridgeBio Pharma Inc Common

60/100

-2

JAZZ

Jazz Pharmaceuticals Public Ltd Co Common

60/100

-2

LLY is the first peer returned for this comparison set.